Prevention of ovarian hyperstimulation syndrome (OHSS): British Fertility Society policy and practice guideline
Authors:
Open Access
- 19 December 2024
- journal article
- research article
- Published by Taylor & Francis in Human Fertility
- Vol. 28 (1) , 2441827
Abstract
This British Fertility Society (BFS) Policy and Practice guideline aims to support clinicians in preventing ovarian hyperstimulation syndrome (OHSS) in patients undergoing gonadotropin ovarian stimulation. A systematic literature search of the medical databases was performed. The Guideline Development Group (GDG) identified the risk factors of OHSS before and during ovarian stimulation. The relation of different pre-treatment measures and different ovarian stimulation protocols with OHSS was evaluated. The optimal monitoring during treatment was assessed. The current evidence on preventive strategies during and after ovarian stimulation and the available adjuvant preventive agents were examined. Based on this, the GDG developed evidence-based, graded recommendations for clinical practice. The evidence was evaluated within context, considering the effectiveness, cost and practical problems of assisted reproductive technology for patients and healthcare providers. Early identification and application of preventive measures identified in this guideline may reduce the incidence of OHSS or reduce its severity. Suggestions for future research on OHSS prevention are provided.Keywords
This publication has 100 references indexed in Scilit:
- Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI)Cochrane Database of Systematic Reviews, 2021
- Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndromeCochrane Database of Systematic Reviews, 2020
- Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndromeCochrane Database of Systematic Reviews, 2020
- In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproductionCochrane Database of Systematic Reviews, 2018
- Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniquesCochrane Database of Systematic Reviews, 2017
- Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndromeCochrane Database of Systematic Reviews, 2017
- Gonadotrophin-releasing hormone antagonists for assisted reproductive technologyCochrane Database of Systematic Reviews, 2016
- Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cyclesCochrane Database of Systematic Reviews, 2016
- Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technologyCochrane Database of Systematic Reviews, 2014
- Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cyclesCochrane Database of Systematic Reviews, 2011